Application 210060

Type
ANDA
Sponsor
ALEMBIC PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEFERASIROXDEFERASIROXTABLET, FOR SUSPENSION;ORAL125MGNoNo
002DEFERASIROXDEFERASIROXTABLET, FOR SUSPENSION;ORAL250MGNoNo
003DEFERASIROXDEFERASIROXTABLET, FOR SUSPENSION;ORAL500MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
46708-324DeferasiroxDeferasiroxAlembic Pharmaceuticals LimitedANDACurrent
46708-325DeferasiroxDeferasiroxAlembic Pharmaceuticals LimitedANDACurrent
46708-326DeferasiroxDeferasiroxAlembic Pharmaceuticals LimitedANDACurrent
62332-324DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-324DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-324DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-324DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-325DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-325DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-325DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-325DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-326DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-326DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-326DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent
62332-326DeferasiroxDeferasiroxAlembic Pharmaceuticals Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
61212ORIG2019-12-10